Taysha Gene Therapies, Inc. (TSHA)
$4.49+1.35%Close
SELLCRISIS · day 13
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.5B
- Beta
- 1.17
- P/E (TTM)
- -10.39
- Short % float
- 23.35%
- Days to cover
- 11.2
- SI change
- +7.0%
- 1W
- -3.02%
- 1M
- -12.98%
- vs SPY 1W
- -4.18%
- vs SPY 1M
- -15.98%
Industry peers
FMP comparable companies · ranked by market cap
- DNTHSELLDianthus Therapeutics, Inc.$4.9BCRISISQ 2$88.04-0.07%
- ELVNSELLEnliven Therapeutics, Inc.$3.2BCRISISQ 11$45.47+0.86%
- ATAIBUYAtai Beckley Inc.$2.7BBULLQ -2$7.35+0.00%
- XNCRSELLXencor, Inc.$1.9BRECOVERYQ 15$25.63+0.53%
- ANABSELLAnaptysBio, Inc.$1.5BCRISISQ 25$49.20-0.56%
- NKTRSELLNektar Therapeutics$1.2BCRISISQ 12$42.22+0.91%
- IMTXSELLImmatics N.V.$1.0BCRISISQ 6$7.73+0.81%
- SANASELLSana Biotechnology, Inc.$801MCRISISQ -5$2.88+0.00%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
